Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-06-29
1987-01-13
Hendricks, Glenna M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514212, 514323, 514414, 546201, 548504, 548507, 540602, A61K 3140, C07D20914
Patent
active
046365214
ABSTRACT:
Compounds are disclosed of general formula (I) ##STR1## wherein R.sub.1 represents an alkyl, cycloalkyl, aryl or aralkyl group;
REFERENCES:
patent: 3472870 (1969-10-01), Larsen et al.
patent: 4064255 (1977-12-01), Champseix et al.
patent: 4180509 (1979-12-01), Metcalf et al.
patent: 4252803 (1981-02-01), Webb
Espamer V., "Gramine Derivatives Antagonistic to 5-Hydroxytryptamine," Science 121: 369-370 (1955).
Freter et al., "Amidomethylierung Indolen," Liebigs Ann. Chem. 1976, pp. 241-249.
Shaw., New Agents Inhibitory to . . . Effects of Serotonin," Chem. Abst. 50:14127 (1955).
Shaw and Woolley, "Indole Carboxamidines and Aminomethylindoles . . . ," J.A.C.S. vol. 79: pp. 3561-3564 (1957).
Bays David E.
Coates Ian H.
Dowle Michael D.
Mills Keith
Webb Colin F.
Glaxo Group Limited
Hendricks Glenna M.
LandOfFree
3 amino alkyl indoles for use in treating migraine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3 amino alkyl indoles for use in treating migraine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3 amino alkyl indoles for use in treating migraine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2356065